Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/09/21 EDT
64.92quote price arrow down-0.19 (-0.29%)
Volume
139,581
Close
65.11quote price arrow up+0.09 (+0.14%)
Volume
5,689,993
52 week range
56.56 - 85.79

...

Loading . . .
  • Open64.82
  • Day High65.25
  • Day Low64.24
  • Prev Close65.02
  • 52 Week High85.79
  • 52 Week High Date04/17/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap81.977B
  • Shares Out1.259B
  • 10 Day Average Volume7.00M
  • Dividend2.84
  • Dividend Yield4.36%
  • Beta0.41
  • YTD % Change11.76

KEY STATS

  • Open64.82
  • Day High65.25
  • Day Low64.24
  • Prev Close65.02
  • 52 Week High85.79
  • 52 Week High Date04/17/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20
  • Market Cap81.977B
  • Shares Out1.259B
  • 10 Day Average Volume7.00M
  • Dividend2.84
  • Dividend Yield4.36%
  • Beta0.41
  • YTD % Change11.76

RATIOS/PROFITABILITY

  • EPS (TTM)0.06
  • P/E (TTM)1,142.28
  • Fwd P/E (NTM)9.01
  • EBITDA (MRQ)5.56B
  • ROE (MRQ)0.60%
  • Revenue (MRQ)24.689B
  • Gross Margin (MRQ)81.48%
  • Net Margin (MRQ)0.36%
  • Debt To Equity (MRQ)172.52%

EVENTS

  • Earnings Date04/28/2021
  • Ex Div Date03/12/2021
  • Div Amount0.71
  • Split Date-
  • Split Factor-

Profile

MORE
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy...
Daniel O'Day
Chairman
Andrew Dickinson
Chief Financial Officer
Jyoti Mehra
Executive Vice President
Brett Pletcher
Executive Vice President
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
AZN
AstraZeneca PLC
49.94+0.44+0.89%
ZTS
Zoetis Inc
159.85-0.15-0.09%
GSK
GlaxoSmithKline PLC
36.65+0.19+0.52%
AMGN
Amgen Inc
248.95+2.07+0.84%
VRTX
Vertex Pharmaceuticals Inc
213.35+3.07+1.46%